For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13537-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13531-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

+ Details

Name:	us-gaap_NoncurrentAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_SalesRevenueGoodsNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Threshold percentage which the entity uses for disclosure.

+ References

No definition available.

+ Details

Name:	vrtx_ThresholdForDisclosurePercentage
Namespace Prefix:	vrtx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=vrtx_IncivekMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=vrtx_KalydecoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_GB
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_XX
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=vrtx_OutsidetheUnitedStatesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Segment Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues from external customers
Product revenues, net	$ 124,942us-gaap_SalesRevenueGoodsNet	$ 137,099us-gaap_SalesRevenueGoodsNet	$ 122,319us-gaap_SalesRevenueGoodsNet	$ 103,461us-gaap_SalesRevenueGoodsNet	$ 128,822us-gaap_SalesRevenueGoodsNet	$ 186,653us-gaap_SalesRevenueGoodsNet	$ 254,789us-gaap_SalesRevenueGoodsNet	$ 267,381us-gaap_SalesRevenueGoodsNet	$ 487,821us-gaap_SalesRevenueGoodsNet	$ 837,645us-gaap_SalesRevenueGoodsNet	$ 1,333,458us-gaap_SalesRevenueGoodsNet
Total revenues	144,556us-gaap_Revenues	178,987us-gaap_Revenues	138,421us-gaap_Revenues	118,451us-gaap_Revenues	351,157us-gaap_Revenues	221,700us-gaap_Revenues	310,750us-gaap_Revenues	328,368us-gaap_Revenues	580,415us-gaap_Revenues	1,211,975us-gaap_Revenues	1,527,042us-gaap_Revenues
Property and equipment, net	715,812us-gaap_NoncurrentAssets				696,911us-gaap_NoncurrentAssets				715,812us-gaap_NoncurrentAssets	696,911us-gaap_NoncurrentAssets
United States
Revenues from external customers
Total revenues									361,074	896,952	1,373,516
Property and equipment, net	676,968				657,587				676,968	657,587
Outside of the United States
Revenues from external customers
Total revenues									219,341	315,023	153,526
Property and equipment, net	38,844				39,324				38,844	39,324
Europe
Revenues from external customers
Total revenues									197,611	279,557	129,786
United Kingdom
Revenues from external customers
Property and equipment, net	33,628				29,970				33,628	29,970
Other
Revenues from external customers
Total revenues									21,730	35,466	23,740
Property and equipment, net	5,216				9,354				5,216	9,354
Minimum \| Revenues, Net
Revenues from external customers
Concentration risk (percent)									10.00%	10.00%	10.00%
Minimum \| Accounts Receivable
Revenues from external customers
Threshold for disclosure (percent)	10.00%				10.00%				10.00%	10.00%
Credit Concentration Risk \| Walgreen Co. \| Revenues, Net
Revenues from external customers
Concentration risk (percent)									12.00%
Credit Concentration Risk \| Walgreen Co. \| Accounts Receivable
Revenues from external customers
Concentration risk (percent)									11.00%
Credit Concentration Risk \| Bupa Home Healthcare Limited \| Accounts Receivable
Revenues from external customers
Concentration risk (percent)									20.00%	14.00%
Credit Concentration Risk \| Janssen Inc. \| Accounts Receivable
Revenues from external customers
Concentration risk (percent)									12.00%
Credit Concentration Risk \| Janssen NV \| Revenues, Net
Revenues from external customers
Concentration risk (percent)										22.00%
Credit Concentration Risk \| Janssen NV \| Accounts Receivable
Revenues from external customers
Concentration risk (percent)										28.00%
Credit Concentration Risk \| AmerisourceBergen Drug Corporation \| Revenues, Net
Revenues from external customers
Concentration risk (percent)										21.00%	32.00%
Credit Concentration Risk \| McKesson Corporation \| Revenues, Net
Revenues from external customers
Concentration risk (percent)										21.00%	29.00%
Credit Concentration Risk \| Cardinal Health Incorporated \| Revenues, Net
Revenues from external customers
Concentration risk (percent)											15.00%
KALYDECO
Revenues from external customers
Product revenues, net									463,750	371,285	171,645
INCIVEK
Revenues from external customers
Product revenues, net									$ 24,071	$ 466,360	$ 1,161,813